[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100359891":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":38,"locations":45,"responsibleParty":60,"collaborators":43,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":43,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":43,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":43,"overallStatus":48,"whyStopped":43,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Docosahexaenoic Acid","EXPERIMENTAL","Docosahexaenoic acid",[13],"Drug: DHA",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo drug","PLACEBO_COMPARATOR","Placebo",[19],"Drug: Placebo",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","DHA",[9],[11],{"type":22,"name":17,"description":17,"armGroupLabels":27,"otherNames":28},[15],[29],"Placebo oral tablet",[31,35],{"name":32,"affiliation":33,"role":34},"Amira Darwish, Lecturer","Tanta University - Faculty of Medicine","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":33,"role":37},"Abeer Salamah, MD","STUDY_DIRECTOR",[39],{"name":40,"role":41,"phone":42,"phoneExt":43,"email":44},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440",null,"sheriefabdelsalam@yahoo.com",[46],{"facility":47,"status":48,"city":49,"state":43,"zip":43,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt","EG",{"type":53,"coordinates":54},"Point",[55,56],31.00192,30.78847,{"lat":56,"lon":55},[59],{"name":47,"role":41,"phone":43,"phoneExt":43,"email":43},{"type":61,"investigatorFullName":47,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":43,"oldOrganization":43},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100359891","phase-3-docosahexaenoic-acid-on-breath-holding-spells-in-children-100359891",false,"NCT03965988","Docosahexaenoic Acid on Breath Holding Spells in Children","Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children with newly diagnosed sprlls\n\nExclusion Criteria Other treatment as iron and piracetam","ALL","1 Month","5 Years",{"count":74,"type":75},60,"ESTIMATED","INTERVENTIONAL",[78],"PHASE3","DHA on Breath Holding Spells",[81],"Breath Holding Attack","2019-05-24",{"date":84,"type":85},"2019-05-29","ACTUAL",{"date":87,"type":85},"2018-05-01",{"date":89,"type":75},"2028-12",{"name":47,"class":6},1]